Mechanisms underlying the protective OPN function in colitis are not known; however, given the severe exacerbation of colitis disease with OPN treatment, these data argue against utilization of such therapy for inflammation-driven tumors such as CRC. The gene discussed is SPP1; the disease is colorectal carcinoma.